CN102652788A - Traditional Chinese medicine composition for treating thrombocytopenic purpura - Google Patents
Traditional Chinese medicine composition for treating thrombocytopenic purpura Download PDFInfo
- Publication number
- CN102652788A CN102652788A CN2012101050282A CN201210105028A CN102652788A CN 102652788 A CN102652788 A CN 102652788A CN 2012101050282 A CN2012101050282 A CN 2012101050282A CN 201210105028 A CN201210105028 A CN 201210105028A CN 102652788 A CN102652788 A CN 102652788A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating thrombocytopenic purpura. The traditional Chinese medicine composition comprises the following components in parts by weight: 24-26 parts of rehmannia glutinosa, 24-26 parts of Chinese yam, 10-12 parts of folium mori, 10-12 parts of medlar, 28-32 parts of Eclipta alba, 10-14 parts of fructus ligustri lucidi, 22-25 parts of hairyvein agrimony, 28-32 parts of calcined keel, 14-16 parts of root of red-rooted salvia, 10-14 parts of radix paeoniae alba, 14-16 parts of radix rehmanniae, 9-11 parts of fried burdock, 0.8-1..0 part of antelope horn powder, 8-10 parts of root bark of peony tree, 4-6 parts of liquorice and 14-16 parts of honeysuckle. The traditional Chinese medicine composition is decocted with water and taken. The traditional Chinese medicine composition disclosed by the invention has the effects of clearing away heat, removing toxicity, cooling blood, removing stasis, tonifying qi, nourishing yin and supplementing kidney; and in addition, aiming at treating purpura, the traditional Chinese medicine composition has the advantages of good curative effect, high curative ratio, low recurrence rate and no any toxic and side effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition of treating the purple abnormal pigmentary deposit on the skin of thrombocytopenic.
Background technology
Thrombocytopenic purpura is divided into two types of constitutional and Secondary cases.Idiopathic thrombocytopenic purpura is a kind of immunity syndrome, is common hemorrhage.Its mechanism is to have antiplatelet antibody in the blood circulation, makes platelet destruction too much, causes purpura, and megalokaryocyte is normal or increase primitivization in the bone marrow.The cause of disease and the pathogenesis of primary disease are not illustrated as yet fully, the then Chang Fanfu outbreak of acute thrombocytopenic purpura, and the course of disease is different in size, and general prognosis still can.Serious thrombocytopenia, can be hemorrhage dead because of intracranial hemorrhage or important organ.Primary disease belongs to the traditional Chinese medical science " speckle ", " blood disorder " category.Normal clinically relevant with multiple factors such as exopathogen, diet, feelings will, labor desires, the pathogenesis polyphyly is intimately smoked to burn, the absurd row of forcing blood and deficient QI failing to control, blood oozing from the body openings or subcuta neous tissue arteries and veins are outer etc., answers dialectical executing to control in the treatment, and symptomatic treatment in acute condition is noted in medication, relieving the primary symptom in a chronic case.Western medicine commonly used, DeGrain, the existing treatment by Chinese herbs time is long, and curative effect is not obvious.
Summary of the invention
The invention discloses a kind of Chinese medicine composition of treating the purple abnormal pigmentary deposit on the skin of thrombocytopenic, this Chinese medicine has heat-clearing and toxic substances removing, cooling blood and removing stasis, the effect of benefiting qi and nourishing yin the kidney invigorating, and the purple abnormal pigmentary deposit on the skin of treatment thrombocytopenic, good effect, cure rate is high, and relapse rate is low, and is without any side effects.
The technical scheme that the present invention adopts is following:
A kind of Chinese medicine composition of treating the purple abnormal pigmentary deposit on the skin of thrombocytopenic is made up of following component, and the weight portion of each component is: Radix Rehmanniae Preparata 24-26, Rhizoma Dioscoreae 24-26, Folium Mori 10-12; Fructus Lycii 10-12, Herba Ecliptae 28-32, Fructus Ligustri Lucidi 10-14, Herba Agrimoniae 22-25, Os Draconis (calcined) 28-32; Radix Salviae Miltiorrhizae 14-16, Radix Paeoniae Alba 10-14, Radix Rehmanniae 14-16, Fructus Arctii (parched) 9-11; Cornu Saigae Tataricae powder 0.8-1.0, Cortex Moutan 8-10, Radix Glycyrrhizae 4-6, Flos Lonicerae 14-16.
The Chinese medicine composition of the purple abnormal pigmentary deposit on the skin of described treatment thrombocytopenic is made up of following component, and the weight portion of each component is: Radix Rehmanniae Preparata 25, Rhizoma Dioscoreae 25, Folium Mori 11; Fructus Lycii 11, Herba Ecliptae 30, Fructus Ligustri Lucidi 12, Herba Agrimoniae 24, Os Draconis (calcined) 30; Radix Salviae Miltiorrhizae 15, the Radix Paeoniae Alba 12, the Radix Rehmanniae 15, Fructus Arctii (parched) 10; Cornu Saigae Tataricae powder 1.0, Cortex Moutan 9, Radix Glycyrrhizae 5, Flos Lonicerae 15.
Usage and consumption: fry in shallow oil water and take, 1 dose of day clothes, every dose of heavy 250g of medicine fries in shallow oil water according to the conventional method of Chinese medicine, divides and has obeyed for 2 to 3 times.1 month is a course of treatment, and the lighter takes and gets final product 1-2 the course of treatment, and purple abnormal pigmentary deposit on the skin severe patient need be taken 5-6 the course of treatment.
Beneficial effect:
Chinese medicine composition medicine of the present invention source is wide, and price is low; Have heat-clearing and toxic substances removing, cooling blood and removing stasis, the effect of benefiting qi and nourishing yin the kidney invigorating, the purple abnormal pigmentary deposit on the skin of treatment thrombocytopenic, good effect, instant effect, cure rate is high; Without any side effects.
Chinese medicine composition of the present invention so far to 465 routine patient's clinical treatments, has given sufficient proof from 2005.
The specific embodiment
A kind of Chinese medicine composition of treating the purple abnormal pigmentary deposit on the skin of thrombocytopenic is made up of following component, and the weight of each component is: Radix Rehmanniae Preparata 25 g, Rhizoma Dioscoreae 25 g, Folium Mori 11 g; Fructus Lycii 11 g, Herba Ecliptae 30 g, Fructus Ligustri Lucidi 12 g, Herba Agrimoniae 24 g, Os Draconis (calcined) 30 g; Radix Salviae Miltiorrhizae 15 g, the Radix Paeoniae Alba 12 g, the Radix Rehmanniae 15 g, Fructus Arctii (parched) 10 g; Cornu Saigae Tataricae powder 1.0 g, Cortex Moutan 9 g, Radix Glycyrrhizae 5 g, Flos Lonicerae 15g.
Usage and consumption: 1 dose of day clothes, fry in shallow oil moisture and obeyed for 2 to 3 times.1 month is a course of treatment, and the lighter takes 1-2 the course of treatment, and purple abnormal pigmentary deposit on the skin severe patient need be taken 5-6 the course of treatment.
Model case
High certain, the man, first visit on November 19 in 42 years old 2006: the patient travel before 10 days and general fatigue occurs after the fatigue, and whole body finds to be dispersed in petechial hemorrhage, hospitalization is then looked into its breast, abdomen is no abnormal, platelet count 47 * 10
9/ L.Bone marrow needle biopsy is diagnosed as former thrombocytopenic purpura.Used leucogen, vitamin K after being admitted to hospital once
4, prednisone, YUNNAN BAIYAO and decoction (GUIPI TANG adds flavor) treatment, but the disease feelings do not have improvement.See patient's flushed face during prescription on individual diagnosis, dizzy heavy, whole body is dispersed in the macule sheet, and color is scarlet, and is tired, vexed.Body of the tongue is light red, and the tongue fur BOHUANG is greasy, and rapid pulse is unable.
The treatment: take Chinese medicine composition of the present invention, day clothes 1 dose, fry in shallow oil moisture and obeyed for 2 to 3 times, take two weeks after, the skin macule, kermesinus disappears, and does not have new petechia, and is dizzy, tired, vexed phenomenon alleviates, body of the tongue is light red, tongue fur BOHUANG, stringy and thready pulse.Continued to take 15 days, the uncomfortable state of health each item disappears, and continues again to take 20 days, and platelet count reaches 158 * 10
9/ L, physical rehabilitation, does not recur with examining so far the back.
Lee man 12 years old Sixian County head on JIUYUE 20th, 2007 examines: in late April, 2007, the purple abnormal pigmentary deposit on the skin of being dispersed in property appearred in two lower limb, and is unable, and low grade fever sometimes is in examination in hospital platelet 34 * 10
9/ L is main with the prednisone medicine, obeys 3 at every turn, one day 3 times, to take medicine more than four months, and platelet is all the time 40 * 10
9/ L to 80 * 10
9Between/the L, leukocyte is 9 * 10
9/ L to 18 * 10
9Between/the L, require to see Chinese medicine.During first visit, easy catching a cold, it is bad that spirit has fashion, diet is general, the tooth epistaxis.Spirit is not good enough, moon face, and light red tongue, tongue is few, and pharynx is light congested, left volume submental lymph nodes Semen Pisi sativi size, mild tenderness.
Diagnosis: purpura.
Treatment: take Chinese prescription of the present invention, 1 dose of day clothes are fried in shallow oil moisture and have been obeyed for 2 times.Take after two months, inspection once more, platelet is 50 * 10
9/ L to 90 * 10
9Between/the L, leukocyte returns to normal range basically,
Continue to take the top after half a year, reinspection is looked into, and platelet rises to 105 * 10
9/ L to 140 * 10
9Between/the L, leukocyte returns to normal range.
Grandson, the man, first visit on July 11 in 22 years old 2009: it is extremely tired whole body to occur after the patient worked before 10 days, and gingiva is hemorrhage on a small quantity, but not bitterly, before 6 days suddenly epistaxis once, about 400ml, color is red, whole body finds to be dispersed in petechial hemorrhage, then hospitalization.It is no abnormal to look into its breast abdomen, platelet count 90 * 109/L.Bone marrow needle biopsy is diagnosed as thrombocytopenic purpura.Give Chinese medicine composition of the present invention, 1 dose of day clothes are fried in shallow oil moisture and obeys for 2 times, check that platelet count is increased to 100 * 129/L after obey 20 doses of medicines, continue the half a year of taking medicine, and with examining, the recovery of health each item health indicator is normally recurred so far.
Claims (2)
1. a Chinese medicine composition of treating the purple abnormal pigmentary deposit on the skin of thrombocytopenic is characterized in that be made up of following component, the weight portion of each component is: Radix Rehmanniae Preparata 24-26, Rhizoma Dioscoreae 24-26; Folium Mori 10-12, Fructus Lycii 10-12, Herba Ecliptae 28-32, Fructus Ligustri Lucidi 10-14, Herba Agrimoniae 22-25; Os Draconis (calcined) 28-32, Radix Salviae Miltiorrhizae 14-16, Radix Paeoniae Alba 10-14, Radix Rehmanniae 14-16, Fructus Arctii (parched) 9-11; Cornu Saigae Tataricae powder 0.8-1.0, Cortex Moutan 8-10, Radix Glycyrrhizae 4-6, Flos Lonicerae 14-16.
2. the Chinese medicine composition of the purple abnormal pigmentary deposit on the skin of treatment thrombocytopenic according to claim 1 is characterized in that be made up of following component, the weight portion of each component is: Radix Rehmanniae Preparata 25, Rhizoma Dioscoreae 25; Folium Mori 11, Fructus Lycii 11, Herba Ecliptae 30, Fructus Ligustri Lucidi 12, Herba Agrimoniae 24; Os Draconis (calcined) 30, Radix Salviae Miltiorrhizae 15, the Radix Paeoniae Alba 12, the Radix Rehmanniae 15, Fructus Arctii (parched) 10; Cornu Saigae Tataricae powder 1.0, Cortex Moutan 9, Radix Glycyrrhizae 5, Flos Lonicerae 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210105028.2A CN102652788B (en) | 2012-04-12 | 2012-04-12 | Traditional Chinese medicine composition for treating thrombocytopenic purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210105028.2A CN102652788B (en) | 2012-04-12 | 2012-04-12 | Traditional Chinese medicine composition for treating thrombocytopenic purpura |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102652788A true CN102652788A (en) | 2012-09-05 |
| CN102652788B CN102652788B (en) | 2014-07-23 |
Family
ID=46728620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210105028.2A Expired - Fee Related CN102652788B (en) | 2012-04-12 | 2012-04-12 | Traditional Chinese medicine composition for treating thrombocytopenic purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102652788B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199586A (en) * | 2006-12-14 | 2008-06-18 | 北京因科瑞斯生物制品研究所 | Medicament for purpruick |
| CN101313991A (en) * | 2008-07-01 | 2008-12-03 | 王跃进 | Capsule for thrombocytopenic purpura |
| CN102283951A (en) * | 2011-07-28 | 2011-12-21 | 北京中科血康血液病医学研究院 | Chinese medicinal composition for treating anaphylactoid purpura and thrombocytopenic purpura |
-
2012
- 2012-04-12 CN CN201210105028.2A patent/CN102652788B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199586A (en) * | 2006-12-14 | 2008-06-18 | 北京因科瑞斯生物制品研究所 | Medicament for purpruick |
| CN101313991A (en) * | 2008-07-01 | 2008-12-03 | 王跃进 | Capsule for thrombocytopenic purpura |
| CN102283951A (en) * | 2011-07-28 | 2011-12-21 | 北京中科血康血液病医学研究院 | Chinese medicinal composition for treating anaphylactoid purpura and thrombocytopenic purpura |
Non-Patent Citations (2)
| Title |
|---|
| 古学奎等: "分期辨治难治性原发性血小板减少性紫癜57例疗效观察", 《新中医》 * |
| 王敬杰: "中医药治疗特发性血小板减少性紫癜研究进展", 《天津中医药》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102652788B (en) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine | |
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN103463568B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN105147811B (en) | A kind of external medicine composition and preparation method thereof for preventing and treating hand-foot syndrome | |
| CN102379968B (en) | Traditional Chinese medicine composition for treating purpura | |
| CN103432545A (en) | Medicament for allaying fever of child and preparation method thereof | |
| CN101972415A (en) | Traditional Chinese medicine-decocted soup or granule preparation for recuperating and treating diabetes | |
| CN102631450B (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102652788B (en) | Traditional Chinese medicine composition for treating thrombocytopenic purpura | |
| CN104721629B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of iron Deficiency Anemia | |
| CN102652789B (en) | Traditional Chinese medicine for treating thrombocytopenic purpura | |
| CN103638389A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN102652787B (en) | Traditional Chinese medicine (TCM) extract for treating idiopathic thrombocytopenic purpura (ITP) | |
| CN103142914B (en) | Traditional Chinese medicine for lowering blood sugar | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN102805795B (en) | Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN102652807A (en) | Traditional Chinese medicine composition for treating anaphylactic purple macula | |
| CN102652806A (en) | Traditional Chinese medicine for treating anaphylactic purple macula | |
| CN105687757A (en) | Traditional Chinese medicine composition for treating phlegm-qi stagnation type hyperthyreosis with automatic junctional tachycardia | |
| CN105056136A (en) | Traditional Chinese medicine composition for treating non-small-cell lung cancer hypercoagulability | |
| CN102698087B (en) | Medicament for treating acute gastrorrhagia and preparation method of medicament | |
| CN104587017A (en) | Pharmaceutical composition for clearing heat and relaxing bowels, promoting qi and activating blood circulation as well as preparation method and application of pharmaceutical composition | |
| CN103655698A (en) | Medicament for treating psoriasis and application of medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20150412 |
|
| EXPY | Termination of patent right or utility model |